STORY FROM: Drugs & Medical Devices
Brand-Name Drug Makers Can be Held Liable for Inadequately Labeled Generics, Mass. High Court Rules
March 19, 2018
BOSTON — Brand-name drug makers can be held liable for inadequate warnings on the labels of generic equivalents, Massachusetts highest court has held in reinstating a negligent failure-to-warn claim against Merck & Co. in a prostate drug action.
In a March 16 opinion, the Massachusetts Supreme Judicial Court directed the trial court to determine whether Merck’s failure to update its Proscar label — the language of which was adopted by the makers of the generic equivalent — rose to the standard of “a reckless disregard of an unreasonable risk of death or grave bodily injury.”
In August, 2010, Brian Rafferty ...
Associated Law Firms